Author: Matthew Nelson|| Date Published: December 16, 2019
McKesson (NYSE: MCK) has received a potential eight-year contract of undisclosed value to provide pharmaceutical supplies to outpatient clinics, medical centers and the Department of Veterans Affairs consolidated mail outpatient pharmacies.
Efforts under the contract are intended to support over 750 sites and seven CMOPs operated by the VA, the companysaid Thursday.
Contract work has a base period of two years starting in August and could extend to six more years if all options are exercised.
We are honored to once again be selected for the important responsibility of serving those who serve us and providing quality care for our veterans, said Brian Tyler, CEO at McKesson.
The U.S. Space Force plans to modify its Andromeda indefinite-delivery/indefinite-quantity contract to raise the total ceiling to $6.24 billion. Lockheed Martin,…
CACI International has appointed Christopher Monoski as executive vice president of manufacturing. Monoski will report to President and CEO John Mengucci and join…